CES focused on AI and accelerated compute. These companies are likely to benefit.
[ad_1]
CES focused on AI and accelerated compute. These companies are likely to benefit.
[ad_2]
[ad_1] Halozyme raises 2025 guidance, announces $250M stock buyback [ad_2]
[ad_1] InnSuites Hospitality Trust declares $0.01 dividend [ad_2]
[ad_1] Eli Lilly (NYSE:LLY) has agreed to buy Scorpion Therapeutics’ lead drug program for up to $2.5B in cash and spin out the remaining company as a new entity focused on precision medicine. Scorpion’s lead drug asset, a mutant-selective PI3Kα inhibitor known [ad_2]
[ad_1] Valuation concerns and revenue slump drives downgrade to Choice and Sunstone Hotels [ad_2]
[ad_1] WisdomTree International Equity Fund declares quarterly distribution of $0.3718 [ad_2]
[ad_1] Cap weighted SPY vs. equal weight RSP: Identical returns over the last 6 months [ad_2]